New report on Cost effectiveness of CPAP for Treatment of OSA

Deloitte Access Economics have just completed a study, commissioned by the Sleep Health Foundationn into the cost effectiveness of continuous positive airway pressure (CPAP) therapy for obstructive sleep apnoea (OSA).

The study assesses the cost effectiveness of CPAP – or value for money – compared to no care from two perspectives: (a) costs to the health care system including costs of the treatment intervention and those of OSA-related health care utilisation and their changes with treatment; and (b) overall costs to society, which include health care system costs together with other financial costs, including those related to productivity, non-health related accident costs and informal care, and their changes with treatment.

More information